Cargando…
NPLOC4 is a potential target and a poor prognostic signature in lung squamous cell carcinoma
Few prognostic biomarkers exist for lung squamous cell carcinoma (LUSC), which has a poor five-year survival rate. Using bioinformatics, this study evaluated NPLOC4 as a prognostic marker for patients with lung squamous cell carcinoma. Shorter survival periods and tumor growth were linked to high NP...
Autores principales: | Wang, Naixue, Zhu, Dantong, Liu, Yao, Wu, Jingran, Wang, Meiling, Jin, Shanxiu, Fu, Fangwei, Li, Baolei, Ji, Hongjuan, Du, Cheng, Zheng, Zhendong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665339/ https://www.ncbi.nlm.nih.gov/pubmed/37993584 http://dx.doi.org/10.1038/s41598-023-47782-6 |
Ejemplares similares
-
Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways
por: Liu, Yao, et al.
Publicado: (2022) -
The p97‐Nploc4 ATPase complex plays a role in muscle atrophy during cancer and amyotrophic lateral sclerosis
por: Re Cecconi, Andrea David, et al.
Publicado: (2022) -
Current status and prospects of GREM1 research in cancer (Review)
por: Zhu, Dantong, et al.
Publicado: (2023) -
A commonly occurring genetic variant within the NPLOC4–TSPAN10–PDE6G gene cluster is associated with the risk of strabismus
por: Plotnikov, Denis, et al.
Publicado: (2019) -
Unique genomic features and prognostic value of COSMIC mutational signature 4 in lung adenocarcinoma and lung squamous cell carcinoma
por: Cai, Xiuyu, et al.
Publicado: (2020)